0 Bedömningar
ID

26045

Beskrivning

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Pharmacokinetics - Repeating form (Scheduled visits)

Nyckelord

Versioner (4)
  1. 2017-10-05 2017-10-05 -
  2. 2017-10-16 2017-10-16 -
  3. 2017-10-23 2017-10-23 -
  4. 2018-01-03 2018-01-03 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

5 oktober 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

  • Senaste
  • Äldsta
  • Önskad
  • Senaste
    • Senaste
    • Äldsta
    • Önskad

    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    Pharmacokinetics GSK study Chronic Coronary Heart Disease NCT00799903

    Engelsk

    Pharmacokinetics GSK study Chronic Coronary Heart Disease NCT00799903

    1 Formulär  
    An unscheduled PK blood sample must be obtained within 72 hours of last dose
    Beskrivning

    An unscheduled PK blood sample must be obtained within 72 hours of last dose

    1. Was a pharmacokinetic blood sample obtained?
    Beskrivning

    pharmacokinetic blood sample

    Datatyp

    boolean

    If yes, date taken
    Beskrivning

    Date of blood sample

    Datatyp

    date

    If yes, time taken
    Beskrivning

    Time of blood sample

    Datatyp

    time

    If Yes, date of last investigational product dose prior to PK sample
    Beskrivning

    date of last investigational product dose prior to PK sample

    Datatyp

    date

    If Yes, time of last investigational product dose prior to PK sample
    Beskrivning

    time of last investigational product dose prior to PK sample

    Datatyp

    time

    Sample Identifier/Sample Number
    Beskrivning

    Sample Identifier and Sample Number are conditional. The study team must choose one for inclusion on the eCRF form.

    Datatyp

    text

    Tillbaka till toppen

    Similar models

    Pharmacokinetics GSK study Chronic Coronary Heart Disease NCT00799903

    1 Formulär
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    An unscheduled PK blood sample must be obtained within 72 hours of last dose
    pharmacokinetic blood sample
    Item
    1. Was a pharmacokinetic blood sample obtained?
    boolean
    Date of blood sample
    Item
    If yes, date taken
    date
    Time of blood sample
    Item
    If yes, time taken
    time
    date of last investigational product dose prior to PK sample
    Item
    If Yes, date of last investigational product dose prior to PK sample
    date
    time of last investigational product dose prior to PK sample
    Item
    If Yes, time of last investigational product dose prior to PK sample
    time
    Sample Identifier/Sample Number
    Item
    Sample Identifier/Sample Number
    text
    Tillbaka till toppen 

    Hjälp

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial